February 13th 2025
The FDA approved an expanded label for avacincaptad pegol, removing limitations on the duration of dosing beyond 12 months.
February 10th 2025
FDA Approves Minocycline Hydrochloride Extended Release Capsules for Individuals with Rosacea
The approval by the FDA of minocycline hydrochloride modified release capsules, also known as DFD-29, will allow for treatment of inflammatory lesions and erythema among adults.